|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.06.26 - 15:06
|
Within3 Appoints Erin Mistry as Chief Executive Officer (Business Wire)
|
|
|
Global biopharma executive and commercial strategist to lead the company's next chapter of growthCLEVELAND--(BUSINESS WIRE)--#AI--Within3, the leading Launch Intelligence™ platform for life sciences, today announced the appointment of Erin Mistry as Chief Executive Officer. Mistry brings more than 20 years of experience in global biopharma commercialization, having launched and priced more than 20 pharmaceutical products across eight therapeutic areas.
Most recently, Mistry served as Chief Commercial Officer at CorMedix, where she led the launch of DefenCath and drove the company to break-even within six months and profitability in under a year. Earlier, she held senior global leadership roles at Syneos Health and Jupiter Life Sciences, as well as industry roles at MedImmune and AstraZeneca. She serves on the Executive Policy Council at the Harvard T.H. Chan School of Public Health and is a member of the Pharma AI Council.
Jason Smith, Within3's Chief Technology Officer, said: “Erin has spent her ca...
|
|
|
|
|
|
|
15.05.26 - 14:33
|
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:...
|
|
|
|
|
|
|
|
|
|
|
|
|
|